All Clarivate Analytics websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.

More information on our cookie policy.

BioWorld. Link to homepage.

/images/Cortellis_Flagship_Logo_TM_RGB_Color.png
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
  • Special reports
    • Artificial intelligence
    • Coronavirus
    • Diagnosing and tracking COVID-19
    • Drugs to Watch 2020
    • The next pandemic
    • Premium reports
      • BioWorld Financings Reports
      • Disease Forecast Reports

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Thursday, February 25, 2021
Home » Blogs » BioWorld MedTech Perspectives » Mind over matter

BioWorld MedTech Perspectives
BioWorld MedTech Perspectives RSS FeedRSS

BioWorld MedTech

Mind over matter

Feb. 27, 2013
By Omar Ford
No Comments
brainweights

She was probably a little more than 5-feet-tall... and close to 160 pounds of pure muscle. On a day unlike any other, I crossed the path of this 60-year-old woman (though she doesn't look a day over 40) who is an avid bodybuilder, at the gym I often work out in.

We were both headed to a piece of equipment to do pull-ups - I was by myself, she was with a cadre of women that she was training. As I was about to get on the machine she cut me off rather quickly and hopped on it before I got the chance.

"Hey," I told her. "I was just going to get on that."

She gave a quick glance back toward me and rolled her eyes. She then proceeded to do about 50 pulls ups before stepping away from the machine.

No doubt physical fitness is a main priority for her as it is for a great deal of enthusiasts at the gym, but are they focused on their mental fitness or their brain health? Shortly after I had my encounter with her, I had the chance to talk to a company called SharpBrains, a firm that serves as an advocate for brain health.

It was amazing to me that in my discussion with SharpBrains CEO Alvaro Fer­nan­dez, that there is a cultural shift regarding neurological diseases and that many companies are developing programs and techniques to prevent these diseases from setting in.

The market for this concept is rapidly growing – expected to jump from the current level of $1 billion to about $6 billion in 2020 – according to the SharpBrains newly released study, the Digital Brain Health Market 2012-2020.

The 211-page market report tracks developments at more than fifty public and private companies offering fully automated applications designed to assess, monitor and/or enhance cognition and brain functioning, and provides industry data, insights and analysis to help executives, entrepreneurs, technology/health innovators and policy makers navigate the opportunities and risks of the rapidly growing Digital Brain Health field.

In summary, he said that patients are going to be doing more and more to preserve their brain health alongside their physical health. So the next time I see my 60-year-old workout nemesis, it might be worth a mention to her to look into what the company is doing - that is if I can muster up the courage to look her in the eye after our last encounter.

You must login or register in order to post a comment.

Report Abusive Comment

Popular Stories

  • Free access to BioWorld coronavirus articles

    BioWorld

    The articles in this collection are from BioWorld’s ongoing coverage of the COVID-19 coronavirus outbreak. Note that we have added three critical tables which are...

  • Seniors with wooden puzzle

    Cassava’s simufilam improves AD patients’ cognition, behavior

    BioWorld
    When Cassava Sciences Inc.’s president and CEO, Remi Barbier, opened up the interim analysis of the company’s open-label study for Alzheimer’s disease candidate...
  • Vaxart COVID-19 vaccine tablets

    Vaxart shares shaken despite apparently positive early data for oral COVID-19 vaccine

    BioWorld
    Vaxart Inc. investors who stuck by company shares Feb. 3 had to swallow a bitter pill – watching shares of the oral vaccine developer (NASDAQ:VXRT) fall 57.8% to...
  • IPO money

    Lucira Health launches $153M IPO

    BioWorld MedTech
    Infectious diseases diagnostics company Lucira Health Inc. launched an IPO of 9 million shares of common stock at $17 per share, for expected gross proceeds of...
  • Today's news in brief

    BioWorld
    BioWorld briefs for Feb. 25.
cortellis ad

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.

Subscribe
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld MedTech
    • Today's news
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • BioWorld Science
    • About
    • Archives
    • Today's news
    • Search BioWorld Science
  • More
    • About
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
A Clarivate Analytic solution. Link to Clarivate website.
Follow Us

Copyright ©2021. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing